Akebia Therapeutics, Inc. - Common Stock (AKBA)
CUSIP: 00972D105
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 263,222,327
- Total 13F shares
- 12,209,438
- Share change
- +5,189,071
- Total reported value
- $125,630,881
- Put/Call ratio
- 83%
- Price per share
- $10.29
- Number of holders
- 70
- Value change
- +$52,360,330
- Number of buys
- 57
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972D105:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
|
Company |
0.58%
|
1,516,387
|
$16,847,000 | — | 31 Mar 2015 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.47%
|
1,238,436
|
$13,759,000 | — | 31 Mar 2015 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.17%
|
444,704
|
$11,110,000 | — | 31 Mar 2015 | |
| FMR LLC |
13F
|
Company |
0.28%
|
724,200
|
$8,046,000 | — | 31 Mar 2015 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.23%
|
597,363
|
$6,637,000 | — | 31 Mar 2015 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.23%
|
594,534
|
$6,605,000 | — | 31 Mar 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.18%
|
474,023
|
$5,266,000 | — | 31 Mar 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.11%
|
287,842
|
$3,198,000 | — | 31 Mar 2015 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.1%
|
257,090
|
$2,121,000 | — | 31 Mar 2015 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.05%
|
138,676
|
$1,541,000 | — | 31 Mar 2015 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
103,294
|
$1,145,000 | — | 31 Mar 2015 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.04%
|
100,300
|
$1,114,000 | — | 31 Mar 2015 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.04%
|
94,000
|
$1,044,000 | — | 31 Mar 2015 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.03%
|
86,492
|
$961,000 | — | 31 Mar 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
80,884
|
$899,000 | — | 31 Mar 2015 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.03%
|
73,754
|
$819,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
55,825
|
$620,000 | — | 31 Mar 2015 | |
| Employees Retirement System of Texas |
13F
|
Company |
0.02%
|
50,000
|
$556,000 | — | 31 Mar 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
42,938
|
$477,000 | — | 31 Mar 2015 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
34,914
|
$388,000 | — | 31 Mar 2015 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.02%
|
42,910
|
$354,000 | — | 31 Mar 2015 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
31,650
|
$352,000 | — | 31 Mar 2015 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
28,937
|
$321,000 | — | 31 Mar 2015 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
27,742
|
$309,000 | — | 31 Mar 2015 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.01%
|
23,900
|
$266,000 | — | 31 Mar 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.01%
|
22,506
|
$250,000 | — | 31 Mar 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
21,012
|
$234,000 | — | 31 Mar 2015 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
20,895
|
$233,000 | — | 31 Mar 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
20,328
|
$226,000 | — | 31 Mar 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
19,000
|
$211,000 | — | 31 Mar 2015 | |
| DEARBORN PARTNERS LLC |
13F
|
Company |
0.01%
|
18,020
|
$200,000 | — | 31 Mar 2015 | |
| ProShare Advisors LLC |
13F
|
Company |
0.01%
|
17,902
|
$199,000 | — | 31 Mar 2015 | |
| Swiss National Bank |
13F
|
Company |
0.01%
|
17,200
|
$191,000 | — | 31 Mar 2015 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.01%
|
17,002
|
$188,000 | — | 31 Mar 2015 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
14,544
|
$162,000 | — | 31 Mar 2015 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
12,775
|
$142,000 | — | 31 Mar 2015 | |
| Rotella Capital Management, Inc. |
13F
|
Company |
0%
|
12,500
|
$139,000 | — | 31 Mar 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
11,876
|
$132,000 | — | 31 Mar 2015 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0%
|
11,659
|
$130,000 | — | 31 Mar 2015 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0%
|
11,062
|
$123,000 | — | 31 Mar 2015 | |
| ALPS ADVISORS INC |
13F
|
Company |
0%
|
10,041
|
$112,000 | — | 31 Mar 2015 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0%
|
9,500
|
$106,000 | — | 31 Mar 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
8,113
|
$91,000 | — | 31 Mar 2015 | |
| Nationwide Fund Advisors |
13F
|
Company |
0%
|
5,580
|
$62,000 | — | 31 Mar 2015 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
5,100
|
$57,000 | — | 31 Mar 2015 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
4,926
|
$54,728 | — | 31 Mar 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,415
|
$49,000 | — | 31 Mar 2015 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
3,686
|
$41,000 | — | 31 Mar 2015 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,091
|
$34,000 | — | 31 Mar 2015 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
2,873
|
$32,000 | — | 31 Mar 2015 |
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2015
As of 30 Jun 2015,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,209,438 shares.
The largest 10 holders included
EAGLE ASSET MANAGEMENT INC, FMR LLC, Novo A/S, BlackRock Fund Advisors, BALYASNY ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Marshall Wace LLP, RENAISSANCE TECHNOLOGIES LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and STATE STREET CORP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
59
Q2 2015 holders
70
Holder diff
11
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.